Robert Latzman

Robert Latzman

Company: Takeda

Job title: Associate Director, Quantitative Sciences


Quantitative Approaches to Advancing Endpoint Development – With a Specific Focus on Cognition 12:00 pm

• How best to identify endpoint targets for clinical trials from a quantitative perspective and optimize biomarkers & endpoints through digital technologies, imaging and patient reported outcomes to develop aggregated targets showing how different endpoints can co-vary • The potential for the approach to identify aggregated outcomes in the psychiatry be used in other disease…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.